2025 Nobel Prize in Economics goes to…
Joel Mokyr, Philippe Aghion and Peter Howitt. The Nobel Prize committee said that the award…
2025 Nobel Prize in Economics goes to…
Joel Mokyr, Philippe Aghion and Peter Howitt. The Nobel Prize committee said that the award was merited “for having identified the prerequisites for sustained growth through technological progress” The Nobel Prize committee summarizes their key contributions as follows: Over the last two centuries, for the first time in history, the world has seen sustained economic…
AI Investment Is Now Driven by Proof Rather than Promise
Investors, health systems and payers have grown more selective about AI startups in recent years, according to a panel of experts speaking at MedCity News’ INVEST Digital Health conference. Customers and investors alike are now demanding clear evidence of ROI before committing to deals or partnerships. The post AI Investment Is Now Driven by Proof…
WellTheory Raises $14M to Expand Autoimmune Care Platform
WellTheory’s Series A round was led by General Catalyst and included participation from 7wireVentures, Ingeborg Investments, Accel, Box Group, Leaps by Bayer and Up2 Opportunity Fund. The post WellTheory Raises $14M to Expand Autoimmune Care Platform appeared first on MedCity News.
Por qué los huesos frágiles no es solo un problema de las mujeres
Ronald Klein iba en bicicleta por su barrio en North Wales, Pennsylvania, en 2006, cuando intentó saltar una cuneta. “Pero iba demasiado lento; no tenía suficiente impulso”, recordó. Al caer la bicicleta, extendió el brazo izquierdo para amortiguar la caída. No parecía un accidente grave, pero “no podía levantarme”. En la sala de emergencias, las…
Medicare Beneficiaries Have 32 Medicare Advantage Prescription Drug Plans Available, on Average, for 2026
Medicare beneficiaries will have 32 Medicare Advantage plans with prescription drug coverage available to choose from, on average, in 2026.
Kailera Secures $600M to Advance Dual-Targeting Obesity Drug to Global Phase 3 Tests
Bain Capital Private Equity led Kailera Therapeutics’ Series B financing, which will support global Phase 3 tests of KAI-9531, a weekly injectable drug that hits the same targets as Eli Lilly’s blockbuster obesity medication, Zepbound. The capital will also support development of other oral and injectable metabolic medicines in Kailera’s pipeline. The post Kailera Secures…
The Trump Administration Executive Order on Gender Continues to Reverberate
This Policy Watch examines the continued impact the Trump Administration’s Executive Order on gender is having on LGBTQ health policy issues, inlcude the removal of information and data, adoption of new CDC priorities, and approach to new PrEP recommendations.
Patient Recruitment Reimagined: How AI is Key to Clinical Trial Acceleration
In an environment where speed, equity, and scientific rigor are all imperative, modernizing patient recruitment is no longer a future goal. It is a present necessity. The post Patient Recruitment Reimagined: How AI is Key to Clinical Trial Acceleration appeared first on MedCity News.
Meeting Patients Where They Are: A Smarter Path to Financial Health for Providers
Organizations that meet patients where they are financially, digitally, and emotionally are the ones best positioned to support patients in managing their bills while strengthening trust, satisfaction, and long-term loyalty. The post Meeting Patients Where They Are: A Smarter Path to Financial Health for Providers appeared first on MedCity News.
Rethinking The Entry Point to Healthcare in America: Collaboration in Communities
[Sponsored] Healthcare in the U.S. today exists in a complex, fragmented and costly system, and the people this system is designed for deserve a holistic approach to best address their individual health needs. The post Rethinking The Entry Point to Healthcare in America: Collaboration in Communities appeared first on MedCity News.
